共 81 条
[1]
Krag DN(2007)Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol. 8 881-888
[2]
Anderson SJ(2010)Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 11 927-933
[3]
Julian TB(2014)Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update J Clin Oncol. 32 1365-1383
[4]
Krag DN(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA. 310 1455-1461
[5]
Anderson SJ(2011)Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA. 305 569-575
[6]
Julian TB(2013)Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial Lancet Oncol. 14 297-305
[7]
Lyman GH(2014)Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial Lancet Oncol. 15 1303-1310
[8]
Temin S(1999)Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy Ann Surg. 230 72-78
[9]
Edge SB(2014)Use of sentinel lymph node biopsy to select patients for local-regional therapy after neoadjuvant chemotherapy Curr Breast Cancer Rep. 6 10-16
[10]
Boughey JC(2008)Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol. 26 778-785